China Jo-Jo Drugstores, Inc. (CJJD)
USD 1.52
(-5.59%)
USD 1.52
(-5.59%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 17.16 Million USD | 12.11% |
| 2023 | 15.3 Million USD | -4.44% |
| 2022 | 16.02 Million USD | -5.61% |
| 2021 | 16.97 Million USD | 38.59% |
| 2020 | 12.24 Million USD | -12.24% |
| 2019 | 13.95 Million USD | 3.91% |
| 2018 | 13.42 Million USD | 35.34% |
| 2017 | 9.92 Million USD | -8.14% |
| 2016 | 10.8 Million USD | 2.51% |
| 2015 | 10.53 Million USD | 25.17% |
| 2014 | 8.41 Million USD | -1.95% |
| 2013 | 8.58 Million USD | 24.89% |
| 2012 | 6.87 Million USD | 48.91% |
| 2011 | 4.61 Million USD | 22.46% |
| 2010 | 3.77 Million USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q4 | 17.16 Million USD | -5.33% |
| 2024 Q1 | 20.03 Million USD | 30.87% |
| 2024 Q3 | 17.16 Million USD | -14.34% |
| 2024 FY | 17.16 Million USD | 12.11% |
| 2024 Q2 | 20.03 Million USD | 0.0% |
| 2023 Q3 | 15.45 Million USD | -10.17% |
| 2023 FY | 15.3 Million USD | -4.44% |
| 2023 Q1 | 17.58 Million USD | 9.76% |
| 2023 Q2 | 17.2 Million USD | -2.18% |
| 2023 Q4 | 15.3 Million USD | -0.92% |
| 2022 Q1 | 20.36 Million USD | 19.97% |
| 2022 FY | 16.02 Million USD | -5.61% |
| 2022 Q4 | 16.02 Million USD | -3.44% |
| 2022 Q3 | 16.59 Million USD | -4.88% |
| 2022 Q2 | 17.44 Million USD | -14.34% |
| 2021 Q1 | 11.14 Million USD | -9.03% |
| 2021 Q3 | 14.93 Million USD | 12.89% |
| 2021 FY | 16.97 Million USD | 38.59% |
| 2021 Q2 | 13.22 Million USD | 18.72% |
| 2021 Q4 | 16.97 Million USD | 13.66% |
| 2020 Q2 | 12.17 Million USD | 12.69% |
| 2020 FY | 12.24 Million USD | -12.24% |
| 2020 Q3 | 10.96 Million USD | -9.98% |
| 2020 Q4 | 12.24 Million USD | 11.72% |
| 2020 Q1 | 10.8 Million USD | -22.56% |
| 2019 Q3 | 10.48 Million USD | -24.03% |
| 2019 Q1 | 13.7 Million USD | 2.04% |
| 2019 FY | 13.95 Million USD | 3.91% |
| 2019 Q4 | 13.95 Million USD | 33.12% |
| 2019 Q2 | 13.79 Million USD | 0.7% |
| 2018 Q2 | 11.07 Million USD | 5.68% |
| 2018 FY | 13.42 Million USD | 35.34% |
| 2018 Q4 | 13.42 Million USD | -0.52% |
| 2018 Q3 | 13.5 Million USD | 21.88% |
| 2018 Q1 | 10.48 Million USD | 5.63% |
| 2017 Q2 | 13.76 Million USD | 28.28% |
| 2017 Q1 | 10.73 Million USD | -0.65% |
| 2017 FY | 9.92 Million USD | -8.14% |
| 2017 Q4 | 9.92 Million USD | -6.08% |
| 2017 Q3 | 10.56 Million USD | -23.25% |
| 2016 Q1 | 11.77 Million USD | 11.7% |
| 2016 FY | 10.8 Million USD | 2.51% |
| 2016 Q4 | 10.8 Million USD | 5.28% |
| 2016 Q3 | 10.26 Million USD | -9.94% |
| 2016 Q2 | 11.39 Million USD | -3.2% |
| 2015 Q3 | 9.77 Million USD | 16.1% |
| 2015 Q4 | 10.53 Million USD | 7.78% |
| 2015 FY | 10.53 Million USD | 25.17% |
| 2015 Q1 | 7.22 Million USD | -14.2% |
| 2015 Q2 | 8.42 Million USD | 16.59% |
| 2014 Q3 | 18.23 Million USD | 49.83% |
| 2014 FY | 8.41 Million USD | -1.95% |
| 2014 Q1 | 9.12 Million USD | 6.29% |
| 2014 Q4 | 8.41 Million USD | -53.82% |
| 2014 Q2 | 12.16 Million USD | 33.31% |
| 2013 Q4 | 8.58 Million USD | 12.45% |
| 2013 FY | 8.58 Million USD | 24.89% |
| 2013 Q1 | 7.4 Million USD | 7.75% |
| 2013 Q2 | 8.77 Million USD | 18.38% |
| 2013 Q3 | 7.63 Million USD | -12.93% |
| 2012 Q3 | 7.36 Million USD | -2.22% |
| 2012 Q1 | 3.67 Million USD | -20.47% |
| 2012 Q4 | 6.87 Million USD | -6.6% |
| 2012 FY | 6.87 Million USD | 48.91% |
| 2012 Q2 | 7.52 Million USD | 105.04% |
| 2011 FY | 4.61 Million USD | 22.46% |
| 2011 Q1 | 3.96 Million USD | 5.13% |
| 2011 Q4 | 4.61 Million USD | -10.94% |
| 2011 Q3 | 5.18 Million USD | 12.07% |
| 2011 Q2 | 4.62 Million USD | 16.72% |
| 2010 Q2 | 3.31 Million USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | 3.77 Million USD | 0.0% |
| 2010 Q4 | 3.77 Million USD | 6.9% |
| 2010 Q3 | 3.52 Million USD | 6.4% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | - USD | -Infinity% |
| BIMI International Medical Inc. | 7.65 Million USD | -124.231% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 10.86 Million USD | -57.938% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 10.86 Million USD | -57.938% |
| Leafly Holdings, Inc. | - USD | -Infinity% |
| Leafly Holdings, Inc. | - USD | -Infinity% |
| LifeMD, Inc. | 2.75 Million USD | -521.869% |
| LifeMD, Inc. | 2.75 Million USD | -521.869% |
| TRxADE HEALTH, Inc. | 968.00 USD | -1772952.583% |
| PetMed Express, Inc. | 28.55 Million USD | 39.897% |
| Walgreens Boots Alliance, Inc. | 8.32 Billion USD | 99.794% |